Table 3:
Cardiovascular complications associated with SARS-CoV-2 infection
| Pathological manifestation | Features | References |
|---|---|---|
| Acute myocardial injury | Elevated Troponin I and NT-proBNP levels | (Wang et al., 2020) |
| Cardiac Arrhythmia | Sinus tachycardia, malignant and atrial arrhythmia, Hypokalemia | (Goyal et al., 2020; Guo et al., 2020; D. Wang et al., 2020) |
| Viral cardiomyopathy | Cytokine storm, fulminant myocarditis | (Hu et al., 2020; Hua et al., 2020) |
| Myocardial infarction | Myocardial ischemia, imbalance between oxygen demand and supply, hypotension, ST-segment elevation | (Bangalore et al., 2020; Inciardi et al., 2020; Zhou et al., 2020) |
| Cardiogenic shock | Cardiorespiratory arrest, ST-segment elevation, dysrhythmias | (Sánchez-Recalde et al., 2020; Tavazzi et al., 2020) |
| Vascular complications | Venous thromboembolic events (VTEs), coagulopathy, elevated D-dimer | (Klok et al., 2020; Lodigiani et al., 2020; Tang et al., 2020; Zhou et al., 2020a) |